Dosing & Uses
Benign Prostatic Hypertrophy
Pending FDA approval for benign prostatic hypertrophy (BPH)
Next:
Pharmacology
Mechanism of Action
Stimulates caspase, tumor necrosis factor, and B-cell lymphoma pathways in prostate glandular epithelial cells causing loss of cell membrane integrity, mitochondrial metabolic arrest, NRA depletion, NDA lysis and aggregation, and cell fragmentation and loss
Previous
Next:
Images
No images available for this drug.
Previous
Next:
Medscape prescription drug monographs are based on FDA-approved labeling information, unless otherwise noted, combined with additional data derived from primary medical literature.
